Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.

Respir Res · 2023 · PMC10503122 · PMID 37715261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding PAH subtypes, patients with portopulmonary hypertension (PoPH) or HIV-PAH were also more likely to respond favorably to PDE-5i, whereas patients with idiopathic PAH (IPAH) showed a trend to be non-responders.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.